OneStat.com Web Analytics

Pipline

Pipeline

Proven Expertise. A Vision for Growth.
We have an experienced team with the proven ability to develop recombinant protein products and have been successful in gaining FDA drug approval.

We aim to utilize these strengths to pursue a dual path approach targeting growth areas in follow on biologics and diseases with unmet medical needs.

We currently have a number of products in our pipeline with some already moving their way through the FDA's rigorous development phases.

Press Releases

    • May. 8, 2008
      Insmed Announces First Quarter 2008 Financial Results Read More
    • May. 8, 2008
      /C O R R E C T I O N -- Insmed Inc./ Read More
  • Insmed Stock Price